Eli Lilly’s Alzheimer’s Drug Kisunl...

By HEOR Staff Writer

September 30, 2024

Introduction Eli Lilly has achieved a milestone with its Alzheimer's drug Kisunla, recently approved by Japan's health ministry. Donanemab (Kisunla) is an antibody drug designe...
Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools
The Effect of Sedentary Behaviour on Healthy Ageing
The Economic Impact of Fall Prevention in Hospitals: Evaluating the Fall TIPS...
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research
Artificial Intelligence in Elderly Care: Ethical and Responsible Adoption
Pharmacogenetic Screening: A Cost-Effective Strategy in Treating Major Depres...
Thailand’s Healthcare System and the Role of HTA: A Model of Universal ...
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Elderly Technology Acceptance: Enhancing Health and Independence
New Innovations in Elderly Healthcare: Latest PBAC Outcomes